You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

mCRC, HCC, radiopaque beads, vandetanib

Showing 1 - 25 of 2,189
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Carcinoma, Hepatocellular, Metastatic Colorectal Cancer Trial in Bloomsbury (BTG-002814)

Completed
Has Results
  • Carcinoma, Hepatocellular
  • Metastatic Colorectal Cancer
  • Bloomsbury, London, United Kingdom
    University College London Hospital
Jul 15, 2021

DC Bead LUMI Loaded With Doxorubicin for Intermediate

Completed
  • Hepatocellular Cancer
  • Chemoembolization
  • chemoembolization
  • Athens, Attiki, Greece
    Evgenidion Hospital
Jan 5, 2022

Hepatocellular Carcinoma Non-resectable, Metastatic Colorectal Cancer, Liver Cancer Trial in Grafton (Eye90 Microspheres)

Recruiting
  • Hepatocellular Carcinoma Non-resectable
  • +2 more
  • Eye90 Microspheres
  • Grafton, New Zealand
    Auckland District Health Board
Jan 30, 2023

Hepatocellular Carcinoma (HCC) Trial (LC Bead LUMI™ (Radiopaque (RO) Bead) loaded with doxorubicin)

Withdrawn
  • Hepatocellular Carcinoma (HCC)
  • LC Bead LUMI™ (Radiopaque (RO) Bead) loaded with doxorubicin
  • (no location specified)
Apr 19, 2021

Unresectable Hepatocellular Carcinoma (HCC), Liver Metastases From Colorectal Cancer (mCRC) Trial in France, Spain, United

Recruiting
  • Unresectable Hepatocellular Carcinoma (HCC)
  • Liver Metastases From Colorectal Cancer (mCRC)
  • SIRT
  • Clichy, Cedex, France
  • +8 more
Jul 31, 2023

Transarterial Radioembolization in COlorectal MEtastasis of

Not yet recruiting
  • Transarterial Radioembolization
  • Therasphere
  • (no location specified)
Sep 7, 2023

Unresectable Hepatocellular Carcinoma Trial in Guangzhou (dTACE-HAIC, HAIC, dTACE-HAIC protocol)

Recruiting
  • Unresectable Hepatocellular Carcinoma
  • dTACE-HAIC
  • +3 more
  • Guangzhou, Guangdong, China
    the Second Affiliated Hospital of Guangzhou Medical University
Feb 22, 2022

Digestive Cancer, Metastatic Colorectal Cancer, Hepatocellular Carcinoma Trial in France (Blood sampling to build population

Recruiting
  • Digestive Cancer
  • +4 more
  • Blood sampling to build population pharmacokinetics model
  • Auxerre, France
  • +23 more
Aug 30, 2022

Hepatocellular Carcinoma Trial in Sohag (Doxorubicin-Eluting Beads)

Active, not recruiting
  • Hepatocellular Carcinoma
  • Doxorubicin-Eluting Beads
  • Sohag, Egypt
    Sohag University Hospital
May 5, 2022

Obese Trial in Timisoara (Glucose 8 g coated beads (47% w/w), Glucose 12 g coated beads (47% w/w), Glucose 16 g coated beads

Completed
  • Obese
  • Glucose 8 g coated beads (47% w/w)
  • +4 more
  • Timisoara, Romania
    NovaClin Medical Research Center S.R.L
Feb 17, 2023

Medullary Thyroid Cancer Trial in Cordoba, Sevilla (Pralsetinib, Cabozantinib, Vandetanib)

Not yet recruiting
  • Medullary Thyroid Cancer
  • Cordoba, Spain
  • +1 more
Jan 11, 2023

Hepatocellular Carcinoma, Stage I Hepatocellular Carcinoma AJCC v8, Stage IA Hepatocellular Carcinoma AJCC v8 Trial in Portland

Not yet recruiting
  • Hepatocellular Carcinoma
  • +8 more
  • Quality of Life
  • +3 more
  • Portland, Oregon
  • +1 more
Jun 20, 2022

Hepatocellular Cancer, Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma Trial run by the NCI (durvalumab,

Recruiting
  • Hepatocellular Cancer
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Advanced Malignant Tumor, Metastatic Malignant Tumor, Recurrent Malignant Tumor Trial in Houston (Everolimus, Laboratory

Recruiting
  • Advanced Malignant Neoplasm
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 9, 2022

Contraception Trial (Radiopaque Etonogestrel Implant)

Completed
Has Results
  • Contraception
  • Radiopaque Etonogestrel Implant
  • (no location specified)
Feb 2, 2022

Learn More About Order of Different Treatments and Their Effects

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Regorafenib (Stivarga, BAY73-4506)
  • (no location specified)
Nov 13, 2023

Anti-PD-1 Antibody Plus Regorafenib in Refractory Microsatellite

Completed
  • Metastatic Colorectal Adenocarcinoma
  • regorafenib plus anti-PD-1 antibodies
  • Changsha, Hunan, China
    Hunan Cancer hospital
Jul 4, 2023

Metabolic Syndrome, Obesity Trial in Timisoara (coated beads glucose (8 g) and caffeine anhydrous, coated beads glucose (8 g),

Completed
  • Metabolic Syndrome
  • Obesity
  • coated beads glucose (8 g) and caffeine anhydrous
  • +2 more
  • Timisoara, Romania
    Nova-Clin Medical Research Center S.R.L.,
Jan 27, 2023

First Line Treatment for BRAFV600E Mutant Metastatic Colorectal

Completed
  • BRAF V600E Mutation Positive
  • Metastatic Colorectal Cancer
  • Non Interventional study
  • St. Veit/Glan, Austria
  • +33 more
Jan 20, 2023

Assess Lung Shunting of Yttrium-90 Microspheres Using PET/CT

Active, not recruiting
  • Advanced Adult Primary Liver Cancer
  • +3 more
  • positron emission tomography
  • computed tomography
  • Columbus, Ohio
    Arthur G. James Cancer Hospital and Solove Research Institute at
Nov 9, 2022

Magnetic Resonance Imaging in Evaluation of Patient Affected by

Recruiting
  • Colorectal Cancer
  • Hepatic MRI
  • Roma, Italy
    Policlinico Agostino Gemelli
Jul 10, 2023

Metastatic Colorectal Cancer Trial (Anti-PD-1 Monoclonal Antibody + Capecitabine)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Tislelizumab + Capecitabine
  • Best supportive care
  • (no location specified)
Sep 22, 2022

Learn More About Long-Term Responses to Treatment With

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Regorafenib (Stivarga, BAY73-4506)
  • Whippany, New Jersey
    Bayer
Sep 1, 2023

Fruquintinib With PD-1 Inhibitors Versus TAS-102 With

Completed
  • Metastatic Colorectal Adenocarcinoma
  • Changsha, Hunan, China
    Hunan Cancer hospital
Sep 2, 2023

Prostate Cancer Trial (SpaceOAR Vue)

Not yet recruiting
  • Prostate Cancer
  • SpaceOAR Vue
  • (no location specified)
Jan 17, 2023